Sang-Tae Lee
Director/Board Member at DAE HWA PHARMACEUTICAL CO., LTD.
Net worth: 141 769 $ as of 2024-04-29
Sang-Tae Lee active positions
| Companies | Position | Start | End |
|---|---|---|---|
| DAE HWA PHARMACEUTICAL CO., LTD. | Director/Board Member | 2015-03-19 | - |
| Corporate Officer/Principal | 1989-02-28 | - |
Career history of Sang-Tae Lee
Former positions of Sang-Tae Lee
| Companies | Position | Start | End |
|---|---|---|---|
| HLB PHARMACEUTICAL CO., LTD. | Director/Board Member | - | - |
RedoxBio Co., Ltd.
 RedoxBio Co., Ltd. Pharmaceuticals: MajorHealth Technology RedoxBio Co., Ltd. engages in the manufacture and sale of materials for pharmaceutical products. It operates through Hyaluronic Acid and Chemical business divisions. Its products include hyaluronic filler, methylol cephalexin lysinate, sodium hyaluronate, and others. The company was founded on August 26, 2010 and is headquartered in Hwaseong-si, South Korea. | Director/Board Member | - | - |
Statistics
International
| South Korea | 4 |
Operational
| Director/Board Member | 3 |
| Corporate Officer/Principal | 1 |
Sectoral
| Health Technology | 4 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 3 |
|---|---|
| DAE HWA PHARMACEUTICAL CO., LTD. | Health Technology |
| HLB PHARMACEUTICAL CO., LTD. | Health Technology |
 | Health Technology |
- Stock Market
- Insiders
- Sang-Tae Lee
- Experience
